Concepts (182)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Anesthesia, Obstetrical | 8 | 2023 | 22 | 3.090 |
Why?
|
| Ghana | 16 | 2022 | 23 | 1.870 |
Why?
|
| Referral and Consultation | 4 | 2022 | 142 | 1.840 |
Why?
|
| Delivery, Obstetric | 5 | 2017 | 58 | 1.770 |
Why?
|
| Pregnancy | 24 | 2023 | 996 | 1.770 |
Why?
|
| Maternal Health Services | 4 | 2018 | 8 | 1.670 |
Why?
|
| Anesthesiology | 3 | 2023 | 49 | 1.590 |
Why?
|
| Analgesia, Obstetrical | 7 | 2015 | 47 | 1.370 |
Why?
|
| Cost-Benefit Analysis | 2 | 2020 | 185 | 1.250 |
Why?
|
| Cesarean Section | 7 | 2015 | 112 | 1.240 |
Why?
|
| Triage | 3 | 2020 | 71 | 1.170 |
Why?
|
| Infant Mortality | 3 | 2020 | 23 | 1.170 |
Why?
|
| Anesthesia, Spinal | 4 | 2015 | 20 | 1.140 |
Why?
|
| Maternal Mortality | 4 | 2017 | 12 | 1.140 |
Why?
|
| International Cooperation | 2 | 2017 | 28 | 1.130 |
Why?
|
| Pregnancy Complications | 3 | 2016 | 105 | 1.040 |
Why?
|
| Anesthetics, Local | 7 | 2009 | 78 | 1.000 |
Why?
|
| Anesthesia, Epidural | 6 | 2014 | 24 | 0.990 |
Why?
|
| Labor, Obstetric | 4 | 2018 | 36 | 0.920 |
Why?
|
| Bupivacaine | 7 | 2009 | 50 | 0.920 |
Why?
|
| Midwifery | 3 | 2020 | 3 | 0.890 |
Why?
|
| Medically Underserved Area | 2 | 2014 | 23 | 0.870 |
Why?
|
| Technology | 1 | 2022 | 8 | 0.820 |
Why?
|
| Amides | 5 | 2004 | 18 | 0.800 |
Why?
|
| Female | 29 | 2023 | 19999 | 0.770 |
Why?
|
| Hospitals, Maternity | 1 | 2020 | 1 | 0.750 |
Why?
|
| Postnatal Care | 1 | 2020 | 5 | 0.740 |
Why?
|
| Humans | 34 | 2023 | 32082 | 0.680 |
Why?
|
| Health Education | 1 | 2020 | 163 | 0.670 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2020 | 172 | 0.630 |
Why?
|
| Infant, Newborn | 10 | 2023 | 673 | 0.620 |
Why?
|
| Adult | 19 | 2020 | 9375 | 0.610 |
Why?
|
| Teaching | 3 | 2018 | 63 | 0.600 |
Why?
|
| Analgesia, Epidural | 4 | 2008 | 50 | 0.590 |
Why?
|
| Capacity Building | 2 | 2019 | 4 | 0.590 |
Why?
|
| Program Evaluation | 6 | 2019 | 185 | 0.580 |
Why?
|
| Organizations | 1 | 2016 | 4 | 0.550 |
Why?
|
| Anesthesia, Conduction | 2 | 2008 | 25 | 0.540 |
Why?
|
| Models, Organizational | 1 | 2016 | 15 | 0.540 |
Why?
|
| Tranexamic Acid | 1 | 2015 | 5 | 0.530 |
Why?
|
| Antifibrinolytic Agents | 1 | 2015 | 16 | 0.520 |
Why?
|
| Magnesium Sulfate | 1 | 2015 | 14 | 0.520 |
Why?
|
| Status Epilepticus | 1 | 2015 | 18 | 0.520 |
Why?
|
| Medication Errors | 1 | 2015 | 22 | 0.520 |
Why?
|
| Pregnancy Outcome | 2 | 2015 | 90 | 0.520 |
Why?
|
| Operating Rooms | 1 | 2015 | 35 | 0.490 |
Why?
|
| Education, Medical, Graduate | 1 | 2015 | 127 | 0.470 |
Why?
|
| Infant | 3 | 2023 | 1061 | 0.460 |
Why?
|
| Decision Making | 1 | 2015 | 194 | 0.430 |
Why?
|
| Fentanyl | 3 | 2002 | 32 | 0.420 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2011 | 17 | 0.390 |
Why?
|
| Analgesics, Opioid | 3 | 2002 | 232 | 0.370 |
Why?
|
| Health Personnel | 3 | 2020 | 121 | 0.350 |
Why?
|
| Dipeptides | 2 | 2000 | 9 | 0.340 |
Why?
|
| Patient Care Team | 1 | 2010 | 129 | 0.320 |
Why?
|
| Neostigmine | 3 | 2009 | 16 | 0.320 |
Why?
|
| Hospitals | 3 | 2017 | 102 | 0.320 |
Why?
|
| Program Development | 3 | 2019 | 97 | 0.310 |
Why?
|
| Hemorrhage | 2 | 2017 | 100 | 0.280 |
Why?
|
| Cholinesterase Inhibitors | 2 | 2009 | 31 | 0.250 |
Why?
|
| Education | 2 | 2018 | 38 | 0.240 |
Why?
|
| Analgesia | 2 | 2004 | 29 | 0.240 |
Why?
|
| Central Nervous System Diseases | 1 | 2004 | 13 | 0.230 |
Why?
|
| Nerve Block | 1 | 2004 | 50 | 0.230 |
Why?
|
| Postural Balance | 1 | 2016 | 182 | 0.230 |
Why?
|
| Pesticides | 1 | 2016 | 199 | 0.220 |
Why?
|
| Time Factors | 3 | 2020 | 2145 | 0.220 |
Why?
|
| Occupational Exposure | 1 | 2016 | 232 | 0.220 |
Why?
|
| Emigrants and Immigrants | 1 | 2016 | 244 | 0.210 |
Why?
|
| Transients and Migrants | 1 | 2016 | 297 | 0.210 |
Why?
|
| Resuscitation | 2 | 2014 | 65 | 0.200 |
Why?
|
| Young Adult | 3 | 2020 | 2665 | 0.200 |
Why?
|
| Piperidines | 1 | 2002 | 118 | 0.190 |
Why?
|
| Feasibility Studies | 1 | 2022 | 294 | 0.190 |
Why?
|
| Pain Measurement | 5 | 2009 | 349 | 0.190 |
Why?
|
| Quality-Adjusted Life Years | 1 | 2020 | 31 | 0.180 |
Why?
|
| Respiration | 1 | 2000 | 27 | 0.180 |
Why?
|
| Health Plan Implementation | 1 | 2020 | 22 | 0.180 |
Why?
|
| Morphine | 1 | 2000 | 44 | 0.180 |
Why?
|
| Adjuvants, Anesthesia | 1 | 2000 | 5 | 0.180 |
Why?
|
| Counseling | 1 | 2020 | 97 | 0.180 |
Why?
|
| Anesthesia, Local | 1 | 2000 | 16 | 0.180 |
Why?
|
| Obstetrics | 1 | 2020 | 26 | 0.170 |
Why?
|
| Adrenergic alpha-Agonists | 1 | 2000 | 42 | 0.170 |
Why?
|
| Mothers | 1 | 2020 | 88 | 0.170 |
Why?
|
| Injections, Spinal | 2 | 2015 | 108 | 0.170 |
Why?
|
| Analgesia, Patient-Controlled | 3 | 2009 | 19 | 0.170 |
Why?
|
| Clonidine | 1 | 2000 | 62 | 0.170 |
Why?
|
| Hispanic Americans | 1 | 2016 | 940 | 0.170 |
Why?
|
| Patient Discharge | 1 | 2020 | 186 | 0.170 |
Why?
|
| Clinical Protocols | 2 | 2019 | 97 | 0.160 |
Why?
|
| Leadership | 1 | 2019 | 37 | 0.160 |
Why?
|
| Intensive Care Units, Neonatal | 1 | 2018 | 33 | 0.160 |
Why?
|
| Cross Infection | 1 | 2018 | 55 | 0.150 |
Why?
|
| Blood Pressure | 3 | 2009 | 846 | 0.150 |
Why?
|
| Armenia | 1 | 2017 | 1 | 0.150 |
Why?
|
| Fetal Mortality | 1 | 2017 | 1 | 0.150 |
Why?
|
| Monte Carlo Method | 1 | 2017 | 18 | 0.150 |
Why?
|
| Stillbirth | 1 | 2017 | 7 | 0.150 |
Why?
|
| Focus Groups | 1 | 2018 | 118 | 0.150 |
Why?
|
| Hypertension, Pregnancy-Induced | 1 | 2017 | 13 | 0.150 |
Why?
|
| Educational Status | 1 | 2018 | 181 | 0.140 |
Why?
|
| Hypotension | 1 | 1997 | 47 | 0.140 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2020 | 357 | 0.140 |
Why?
|
| Risk Adjustment | 1 | 2016 | 26 | 0.130 |
Why?
|
| Prospective Studies | 3 | 2017 | 2282 | 0.130 |
Why?
|
| Demography | 1 | 2016 | 110 | 0.130 |
Why?
|
| Male | 7 | 2019 | 19202 | 0.130 |
Why?
|
| Receptors, GABA-A | 1 | 2015 | 32 | 0.130 |
Why?
|
| Regression Analysis | 1 | 2016 | 292 | 0.130 |
Why?
|
| Developing Countries | 1 | 2015 | 48 | 0.120 |
Why?
|
| Emergencies | 1 | 2015 | 47 | 0.120 |
Why?
|
| Retrospective Studies | 2 | 2017 | 3505 | 0.120 |
Why?
|
| Quality Assurance, Health Care | 1 | 2014 | 72 | 0.110 |
Why?
|
| Monitoring, Physiologic | 1 | 2014 | 73 | 0.110 |
Why?
|
| Curriculum | 1 | 2015 | 213 | 0.110 |
Why?
|
| Middle Aged | 3 | 2018 | 11834 | 0.100 |
Why?
|
| Patient Education as Topic | 1 | 2014 | 271 | 0.100 |
Why?
|
| Regional Health Planning | 1 | 2011 | 8 | 0.100 |
Why?
|
| Education, Nursing | 1 | 2010 | 1 | 0.090 |
Why?
|
| Altruism | 1 | 2010 | 5 | 0.090 |
Why?
|
| Parturition | 1 | 2010 | 10 | 0.090 |
Why?
|
| Injections, Intraventricular | 2 | 2000 | 13 | 0.080 |
Why?
|
| Anesthesia | 1 | 2010 | 64 | 0.080 |
Why?
|
| Cooperative Behavior | 1 | 2010 | 81 | 0.080 |
Why?
|
| Risk Factors | 1 | 2017 | 3880 | 0.080 |
Why?
|
| Treatment Outcome | 2 | 2015 | 3304 | 0.080 |
Why?
|
| Critical Care | 1 | 2010 | 105 | 0.080 |
Why?
|
| Croatia | 1 | 2008 | 1 | 0.080 |
Why?
|
| Organizations, Nonprofit | 1 | 2008 | 6 | 0.080 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2000 | 742 | 0.070 |
Why?
|
| Adolescent | 1 | 2015 | 3568 | 0.070 |
Why?
|
| Needles | 1 | 2005 | 31 | 0.060 |
Why?
|
| Rats | 2 | 2000 | 1592 | 0.060 |
Why?
|
| Total Quality Management | 1 | 2004 | 17 | 0.060 |
Why?
|
| Anesthesia, General | 1 | 2004 | 28 | 0.060 |
Why?
|
| Treatment Failure | 1 | 2004 | 162 | 0.060 |
Why?
|
| Case-Control Studies | 1 | 2016 | 895 | 0.060 |
Why?
|
| Databases, Factual | 1 | 2004 | 354 | 0.050 |
Why?
|
| Antiphospholipid Syndrome | 1 | 2002 | 3 | 0.050 |
Why?
|
| Thrombocytopenia | 1 | 2002 | 30 | 0.050 |
Why?
|
| Infusions, Intravenous | 1 | 2002 | 100 | 0.050 |
Why?
|
| Renal Insufficiency | 1 | 2002 | 58 | 0.050 |
Why?
|
| Pain, Postoperative | 1 | 2004 | 178 | 0.050 |
Why?
|
| Fetus | 1 | 2002 | 86 | 0.050 |
Why?
|
| Pre-Eclampsia | 1 | 2002 | 66 | 0.050 |
Why?
|
| North Carolina | 1 | 2016 | 1538 | 0.050 |
Why?
|
| Hypercapnia | 1 | 2000 | 4 | 0.050 |
Why?
|
| Acidosis | 1 | 2000 | 18 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2000 | 66 | 0.050 |
Why?
|
| Carbon Dioxide | 1 | 2000 | 38 | 0.050 |
Why?
|
| Apgar Score | 1 | 2000 | 8 | 0.040 |
Why?
|
| Evidence-Based Practice | 1 | 2020 | 28 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2002 | 629 | 0.040 |
Why?
|
| Clinical Trials, Phase I as Topic | 1 | 2000 | 11 | 0.040 |
Why?
|
| Double-Blind Method | 3 | 2009 | 525 | 0.040 |
Why?
|
| Oxygen | 1 | 2000 | 142 | 0.040 |
Why?
|
| Infection Control | 1 | 2018 | 28 | 0.040 |
Why?
|
| Needs Assessment | 1 | 2019 | 76 | 0.040 |
Why?
|
| Parity | 1 | 1998 | 20 | 0.040 |
Why?
|
| Patient Satisfaction | 1 | 2000 | 240 | 0.040 |
Why?
|
| Stereoisomerism | 1 | 1997 | 22 | 0.040 |
Why?
|
| Guideline Adherence | 1 | 2018 | 120 | 0.040 |
Why?
|
| Pulse | 1 | 1997 | 10 | 0.040 |
Why?
|
| Cerebral Ventricles | 1 | 1997 | 11 | 0.040 |
Why?
|
| Neural Inhibition | 1 | 1997 | 27 | 0.040 |
Why?
|
| Naloxone | 1 | 1997 | 27 | 0.040 |
Why?
|
| Animals | 2 | 2000 | 7510 | 0.040 |
Why?
|
| Attitude of Health Personnel | 1 | 2019 | 184 | 0.040 |
Why?
|
| Pilot Projects | 1 | 2019 | 547 | 0.040 |
Why?
|
| Self Administration | 1 | 1998 | 297 | 0.030 |
Why?
|
| Heart Rate | 1 | 1997 | 335 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2020 | 1427 | 0.030 |
Why?
|
| Aged | 1 | 2016 | 10308 | 0.030 |
Why?
|
| Heart Rate, Fetal | 1 | 2009 | 8 | 0.020 |
Why?
|
| Conscious Sedation | 1 | 2009 | 24 | 0.020 |
Why?
|
| Data Interpretation, Statistical | 1 | 2009 | 109 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2010 | 331 | 0.020 |
Why?
|
| Paresthesia | 1 | 2005 | 9 | 0.020 |
Why?
|
| Catheterization | 1 | 2005 | 58 | 0.020 |
Why?
|
| Injections, Epidural | 1 | 2004 | 9 | 0.010 |
Why?
|
| Postoperative Nausea and Vomiting | 1 | 2004 | 4 | 0.010 |
Why?
|